Safety and performance of the EverProTM everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario

doi:10.4330/wjc.v12.i12.615

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 12

This Article

(230)

(210)

(0)

(13)

(2)

(5400)

(4)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Cohort Study

World J Cardiol. Dec 26, 2020; 12(12): 615-625
Published online Dec 26, 2020. doi: 10.4330/wjc.v12.i12.615

Table 1 Baseline demographics and clinical characteristics

Characteristics	n = 77
Age (mean ± SD), yr	55 ± 11.8
Men, n (%)	59 (76.6)
Medical history, n (%)
Hypertension	37 (48.1)
Diabetes	15 (19.48)
Smoking	24 (31.2)
Consumption of alcohol	9 (11.7)
Stroke	2 (2.6)
Previous coronary intervention	4 (5.2)
Previous myocardial infarction	34 (44.2)
Cardiac status, n (%)
Stable angina	30 (39)
Unstable angina	13 (16.9)
STEMI	26 (33.8)
NSTEMI	8 (10.4)
Coronary angiogram finding, n (%)
Single-vessel disease	61 (79.2)
Double-vessel disease	16 (20.8)
Triple-vessel disease	0 (0.0)
Heart rate (mean ± SD), bpm	81.26 ± 12.08
Systolic blood pressure (mean ± SD), mmHg	134.91 ± 27.51
Diastolic blood pressure (mean ± SD), mmHg	83.19 ± 13.57
Serum creatinine (mean ± SD), mg/dL	1.13 ± 0.23
LVEF (mean ± SD), %	46.38 ± 8.19

LVEF: Left ventricular ejection fraction; NSTEMI: Non-stent thrombosis segment elevation myocardial infarction; SD: Standard deviation; STEMI: Stent thrombosis segment elevation myocardial infarction; bpm: Beats per minute.

Full Size Table

Citation: Trimukhe R, Vani P, Patel A, Salgotra V. Safety and performance of the EverPro^TMeverolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario. World J Cardiol 2020; 12(12): 615-625
URL: https://www.wjgnet.com/1949-8462/full/v12/i12/615.htm
DOI: https://dx.doi.org/10.4330/wjc.v12.i12.615

Trimukhe R, Vani P, Patel A, Salgotra V. Safety and performance of the EverPro^TMeverolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario. World J Cardiol 2020; 12(12): 615-625 [PMID: 33391614 DOI: 10.4330/wjc.v12.i12.615]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.